AstraZeneca PLC (AZN.L) Earnings Per Share (EPS)
Market Cap: $175.47B
Avg Volume: 2.74M
Industry: Drug Manufacturers - General
Sector: Healthcare
Earnings Per Share (EPS) Summary (Annual)
According to AstraZeneca PLC's latest annual financial reports, the company has an earnings per share (EPS) of $4.53 and a diluted EPS of $4.51. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.
The company's EPS growth rate stands at 18.90%, and the diluted EPS growth rate is 18.37%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.
EPS
$4.53
Diluted EPS
$4.51
EPS Growth
18.90%
AstraZeneca PLC Historical EPS
AstraZeneca PLC Historical EPS Growth
EPS History
The table below shows the EPS for each year, with the latest data available for the last fiscal year 2024.
| Year | EPS | Change |
|---|---|---|
| 2024 | $4.53 | 18.90% |
| 2023 | $3.81 | 79.72% |
| 2022 | $2.12 | 2550.00% |
| 2021 | $0.08 | -96.72% |
| 2020 | $2.44 | 136.89% |
| 2019 | $1.03 | -39.41% |
| 2018 | $1.7 | -28.27% |
| 2017 | $2.37 | -14.44% |
| 2016 | $2.77 | 24.22% |
| 2015 | $2.23 | 127.55% |
| 2014 | $0.98 | -51.96% |
| 2013 | $2.04 | -59.12% |
| 2012 | $4.99 | -31.92% |
| 2011 | $7.33 | 30.89% |
| 2010 | $5.6 | 7.90% |
| 2009 | $5.19 | 23.57% |
| 2008 | $4.2 | 12.30% |
| 2007 | $3.74 | -3.11% |
| 2006 | $3.86 | 32.65% |
| 2005 | $2.91 | -98.67% |
| 2004 | $218 | 22.47% |
| 2003 | $178 | 10753.66% |
| 2002 | $1.64 | -0.61% |
| 2001 | $1.65 | 15.38% |
| 2000 | $1.43 | 123.44% |
| 1999 | $0.64 | -56.46% |
| 1998 | $1.47 | 15.75% |
| 1997 | $1.27 | 9.48% |
| 1996 | $1.16 | 110.91% |
| 1995 | $0.55 | -24.66% |
| 1994 | $0.73 | -2.67% |
| 1993 | $0.75 | 341.18% |
| 1992 | $0.17 | -81.11% |
| 1991 | $0.9 | 50.00% |
| 1990 | $0.6 | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for AZN.L.